Skip to content

Protein Intake and Resistance Training in Aging

Different Protein and Derivatives Supplementation Strategies Combined With Resistance Training in Pre-frail and Frail Elderly

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01890382
Enrollment
200
Registered
2013-07-01
Start date
2015-10-01
Completion date
2017-08-30
Last updated
2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frail Elderly Syndrome

Keywords

resistance exercise, protein, creatine, leucine, aging

Brief summary

Resistance training combined with protein or amino acids supplementation has been shown to be promising for mitigating age-related disabilities and comorbidities. Randomized controlled trials supporting this possibility are still scarce. These series of clinical trials aim to investigate the chronic effects of different strategies of protein and derivatives supplementation in association with resistance training on selected health-related parameters in pre-frail and frail elderly.This is a 16-month, double-blind, randomized, placebo-controlled, parallel-group clinical trial involving a series of investigations. Participants will be divided into nine groups, allowing the assessement of the effects of (1) isolated leucine supplementation; (2) protein source (whey vs. soy); (3) combination of whey protein and creatine; and (4) sexual dimorphism to the response of protein intake plus resistance training (men vs. women). All participants will undergo a supervised, resistance training program.

Interventions

DIETARY_SUPPLEMENTWhey protein

30 g in total; twice a day (morning and evening)

DIETARY_SUPPLEMENTwhey plus creatine

whey protein combined with creatine (30 g and 6.0 g in total; twice a day, respectively)

DIETARY_SUPPLEMENTleucine supplementation

7.5 g/d in total; three times per day

DIETARY_SUPPLEMENTsoy protein

30 g in total; twice a day

DIETARY_SUPPLEMENTcreatine

6.0 g in total; twice a day

DIETARY_SUPPLEMENTplacebo

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* elderly people * frailty or pre-frailty, according to Fried et al., (2001) criteria.

Exclusion criteria

* on exogenous insulin and steroid-based drugs * chronic obstructive pulmonary disease or respiratory failure * use of protein and /or amine-based dietary supplements * on restrictive diets (e.g. calorie or food group restrictions) * on resistance training * untreated cardiovascular, metabolic, or other chronic disease * any musculoskeletal condition precluding resistance training

Design outcomes

Primary

MeasureTime frameDescription
muscle function4 monthsassessed by a battery of physical tests
lean mass4 monthsassessed by Dual-energy X-ray absorptiometry

Secondary

MeasureTime frameDescription
bone mass4 monthsassessed by Dual-energy X-ray absorptiometry
insulin sensitivity4 monthsassessed by homeostasis model assessment (HOMA index)
health related-quality of life4 monthsassessed by Short-Form Health Survey (SF-36) (score range: 0 to 100, higher values mean better quality of life)

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026